XML 23 R8.htm IDEA: XBRL DOCUMENT v3.20.4

Statements of Cash Flows (Parenthetical) - USD ($)	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Common Stock And Warrants
Payments of stock issuance costs	$ 7,507,123	$ 158,678
Series C Convertible Preferred Stock
Discount of issuance of common stock, preferred stock and warrants for clinical trial funding commitment		$ 235,640
Series D Convertible Preferred Stock
Discount of issuance of common stock, preferred stock and warrants for clinical trial funding commitment	$ 488,270

X

- Definition

Discount of Issuance of Common Stock, Preferred Stock and Warrants for Clinical Trial Funding Commitment

+ References

No definition available.

+ Details

Name:	trov_DiscountofIssuanceofCommonStockPreferredStockandWarrantsforClinicalTrialFundingCommitment
Namespace Prefix:	trov_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

X

- Definition

The cash outflow for cost incurred directly with the issuance of an equity security.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 15
-URI http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585

+ Details

Name:	us-gaap_PaymentsOfStockIssuanceCosts
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

X

- Details

Name:	us-gaap_StatementClassOfStockAxis=trov_CommonStockAndWarrantsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_StatementClassOfStockAxis=trov_SeriesCConvertiblePreferredStockMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_StatementClassOfStockAxis=trov_SeriesDConvertiblePreferredStockMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type: